AMPH
AMPH clinical trials: Amphastar Pharmaceuticals, Inc.
Every trial on ClinicalTrials.gov where Amphastar Pharmaceuticals, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 21
- Trials linked
- 21
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
AMPH on the catalyst calendar · AMPH registry changes
- Primary completion Jun 22, 2026ActualPhase 2/Phase 3NCT07560150Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting...Amphastar Pharmaceuticals, Inc. · PharmacokineticsCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 29, 2023ActualPhase 2/Phase 3NCT05539872Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart...Amphastar Pharmaceuticals, Inc. · PharmacokineticsCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 20, 2019ActualPhase 4NCT04207840Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular...Amphastar Pharmaceuticals, Inc. · PharmacokineticsCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2010ActualPhase 1/Phase 2NCT01143051Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy VolunteersAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2012ActualPhase 3NCT01460511Evaluation of Efficacy and Safety of E004 in Children With AsthmaAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2009ActualPhase 1/Phase 2NCT01025648Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.Amphastar Pharmaceuticals, Inc. · AsthmaTerminatedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2010ActualPhase 2NCT01189396Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006Amphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2010ActualPhase 1/Phase 2NCT01188577Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of PharmacokineticsAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2012ActualPhase 2NCT01581177Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety EvaluationAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2014ActualPhase 2NCT02271334Evaluation of Pharmacokinetics and Safety of A006 in Healthy VolunteersAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2014ActualPhase 2NCT02210806Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety EvaluationAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2010ActualPhase 2NCT01174732Dose-Ranging Study of A006 DPI, in Adult Asthma PatientsAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2012ActualPhase 3NCT01476904Safety Study in Adolescent and Adult Patients With AsthmaAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2012ActualPhase 2NCT01689363Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)Amphastar Pharmaceuticals, Inc. · Allergic Skin ReactionCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2012ActualPhase 1/Phase 2NCT01737892Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy AdultsAmphastar Pharmaceuticals, Inc. · AsthmaTerminatedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2011ActualPhase 2NCT01255709Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICSAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2013ActualPhase 3NCT01737905Evaluation of Efficacy and Safety for Single Dose of E004 in Children With AsthmaAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2011ActualPhase 3NCT01357642Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma PatientsAmphastar Pharmaceuticals, Inc. · AsthmaCompletedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2008ActualPhase 3NCT00635505Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic PatientsAmphastar Pharmaceuticals, Inc. · AsthmaTerminatedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2008ActualPhase 3NCT00634829Single-Dose Cross-Over Study of the Effects of Albuterol-HFA in Exercise Induced BronchoconstrictionAmphastar Pharmaceuticals, Inc. · AsthmaTerminatedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2008ActualPhase 3NCT006345174-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric AsthmaAmphastar Pharmaceuticals, Inc. · AsthmaTerminatedAMPHLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 21 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner